RS62101B1 - Upotreba probiotika u lečenju i/ili sprečavanju psorijaze - Google Patents

Upotreba probiotika u lečenju i/ili sprečavanju psorijaze

Info

Publication number
RS62101B1
RS62101B1 RS20210883A RSP20210883A RS62101B1 RS 62101 B1 RS62101 B1 RS 62101B1 RS 20210883 A RS20210883 A RS 20210883A RS P20210883 A RSP20210883 A RS P20210883A RS 62101 B1 RS62101 B1 RS 62101B1
Authority
RS
Serbia
Prior art keywords
psoriasis
probiotic composition
treatment
lactis
cect
Prior art date
Application number
RS20210883A
Other languages
English (en)
Serbian (sr)
Inventor
López Vicente Manuel Navarro
Boscá Ana Adela Ramírez
Orquín José Manuel Pérez
Vidal Daniel Ramón
Martínez Salvador Genovés
Cuadros María Empar Chenoll
Cortés Francisco Manuel Codoñer
Original Assignee
Bionou Research S L
Biopolis SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionou Research S L, Biopolis SL filed Critical Bionou Research S L
Publication of RS62101B1 publication Critical patent/RS62101B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/515—Animalis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/531—Lactis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
RS20210883A 2016-03-21 2017-03-21 Upotreba probiotika u lečenju i/ili sprečavanju psorijaze RS62101B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16382122.6A EP3222282A1 (fr) 2016-03-21 2016-03-21 Utilisation de probiotiques dans le traitement et/ou la prévention du psoriasis
PCT/EP2017/056719 WO2017162683A1 (fr) 2016-03-21 2017-03-21 Utilisation de probiotiques dans le traitement et/ou la prévention du psoriasis
EP17722689.1A EP3432899B1 (fr) 2016-03-21 2017-03-21 Utilisation de probiotiques dans le traitement et/ou la prévention du psoriasis

Publications (1)

Publication Number Publication Date
RS62101B1 true RS62101B1 (sr) 2021-08-31

Family

ID=55969084

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20210883A RS62101B1 (sr) 2016-03-21 2017-03-21 Upotreba probiotika u lečenju i/ili sprečavanju psorijaze

Country Status (24)

Country Link
US (1) US10912802B2 (fr)
EP (2) EP3222282A1 (fr)
KR (1) KR102303587B1 (fr)
CN (1) CN110325198B (fr)
AR (1) AR107921A1 (fr)
AU (1) AU2017238300B2 (fr)
DK (1) DK3432899T3 (fr)
EA (1) EA201891908A1 (fr)
ES (1) ES2873889T3 (fr)
HR (1) HRP20211173T1 (fr)
HU (1) HUE055635T2 (fr)
IL (1) IL261932B2 (fr)
MA (1) MA43488B1 (fr)
MX (1) MX389112B (fr)
MY (1) MY193275A (fr)
PE (1) PE20190432A1 (fr)
PH (1) PH12018502042B1 (fr)
PL (1) PL3432899T3 (fr)
PT (1) PT3432899T (fr)
RS (1) RS62101B1 (fr)
RU (1) RU2767967C2 (fr)
SI (1) SI3432899T1 (fr)
UA (1) UA127180C2 (fr)
WO (1) WO2017162683A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800002052A1 (it) 2018-01-26 2019-07-26 Girolamo Stefano Di Probiotico per il trattamento della psoriasi
EP3851115A1 (fr) * 2020-01-15 2021-07-21 Biopolis, S.L. Composition probiotique pour son utilisation en tant qu'antioxydant
US20210275612A1 (en) * 2020-03-09 2021-09-09 Glac Biotech Co., Ltd. Method for alleviating inflammation-related disorder
CN113142554A (zh) * 2020-06-09 2021-07-23 江苏佰澳达生物科技有限公司 一种改善头皮屑产生的益生菌发酵液及其应用
EP3967318A1 (fr) * 2020-09-14 2022-03-16 Bionou Research, S.L. Compositions probiotiques pour le traitement de l'acné
CN112159778B (zh) * 2020-09-30 2021-12-03 江南大学 一株可缓解银屑病的动物双歧杆菌及其应用
WO2022090474A1 (fr) * 2020-10-29 2022-05-05 Deerland Probiotics & Enzymes A/S Composition microbienne micro-encapsulée
CN112546074B (zh) * 2020-12-24 2022-09-27 江南大学 一株能够抑制IL-23、Th17轴相关炎症因子释放的短双歧杆菌及其应用
CN112812989B (zh) * 2020-12-31 2022-06-10 江南大学 一种能够缓解银屑病的青春双歧杆菌及其应用
KR20230156720A (ko) * 2021-02-17 2023-11-14 악시스바이오틱스 리미티드 조성물 및 이의 용도
CN113088473B (zh) * 2021-04-27 2022-08-02 江南大学 一株具有缓解HaCaT细胞氧化损伤作用的动物双歧杆菌
CN113455549B (zh) * 2021-06-29 2022-09-13 黑龙江飞鹤乳业有限公司 一种奶酪产品及其制备方法和应用
ES3048532T3 (en) * 2021-12-16 2025-12-10 Biopolis SL Postbiotic compositions comprising b. longum cect-7347 and l. rhamnosus cect-8361 and therapeutic uses thereof
KR102854932B1 (ko) * 2023-07-03 2025-09-05 코스맥스 주식회사 비피도박테리움 애니멀리스 서브스페시스 락티스 균주 및 그의 모발 또는 두피 상태 개선 용도
CN118421507A (zh) * 2024-04-22 2024-08-02 广东行海生物科技有限公司 一种医用细胞CMU-Pb-12联合地塞米松在制备防治银屑病药物中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050106131A1 (en) * 2002-02-21 2005-05-19 Lionel Breton Photoprotective orally administrable composition for skin
JP2004250337A (ja) 2003-02-18 2004-09-09 Sunstar Inc アレルギー疾患改善用製剤
ZA200802934B (en) * 2005-10-06 2009-09-30 Probi Ab Use of lactobacillus for treatment of virus infections
KR101300086B1 (ko) * 2005-10-06 2013-08-30 프로비 아베 자가면역질환의 치료를 위한 락토바실러스의 용도
ES2343499B1 (es) * 2007-12-24 2011-06-10 Consejo Superior De Investigaciones Cientificas Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten.
WO2012150269A1 (fr) * 2011-05-03 2012-11-08 Dupont Nutrition Biosciences Aps Bactérie probiotique utilisée dans le traitement topique de troubles cutanés
KR20130049554A (ko) 2011-11-04 2013-05-14 주식회사 쎌바이오텍 아토피 예방 또는 치료용 조성물
KR101453982B1 (ko) * 2012-09-19 2014-10-28 주식회사 쎌바이오텍 과민성 대장 증후군 예방 또는 치료용 조성물
ES2526986B1 (es) * 2013-07-18 2015-11-02 Biopolis, S.L. Nueva cepa de Bifidobacterium animalis subsp. lactis CECT 8145 y su uso para el tratamiento y/o prevención de sobrepeso y obesidad y enfermedades asociadas
KR101724601B1 (ko) 2014-11-04 2017-04-10 주식회사 쎌바이오텍 아토피 예방 또는 치료용 조성물
ES2575828B1 (es) * 2014-12-31 2017-07-07 Universidad De León Empleo de probióticos en el incremento de la fertilidad masculina
TWI829098B (zh) * 2015-01-02 2024-01-11 美商梅拉洛伊卡公司 細菌組成物

Also Published As

Publication number Publication date
MX2018011593A (es) 2020-01-30
CN110325198B (zh) 2024-04-30
MA43488B1 (fr) 2020-10-28
RU2018136939A3 (fr) 2020-05-13
BR112018069284A2 (pt) 2019-03-06
EA201891908A1 (ru) 2019-04-30
AU2017238300A1 (en) 2018-11-01
MY193275A (en) 2022-09-29
MA43488A1 (fr) 2019-12-31
PH12018502042B1 (en) 2024-02-21
NZ747129A (en) 2025-02-28
IL261932A (en) 2018-10-31
PH12018502042A1 (en) 2019-07-15
IL261932B (en) 2022-12-01
CN110325198A (zh) 2019-10-11
ES2873889T3 (es) 2021-11-04
US10912802B2 (en) 2021-02-09
WO2017162683A1 (fr) 2017-09-28
AU2017238300B2 (en) 2024-07-11
AR107921A1 (es) 2018-06-28
MX389112B (es) 2025-03-20
PT3432899T (pt) 2021-07-05
HRP20211173T1 (hr) 2021-10-15
RU2767967C2 (ru) 2022-03-23
RU2018136939A (ru) 2020-04-22
PE20190432A1 (es) 2019-03-21
KR102303587B1 (ko) 2021-09-17
SI3432899T1 (sl) 2021-12-31
KR20190008849A (ko) 2019-01-25
EP3432899A1 (fr) 2019-01-30
EP3432899B1 (fr) 2021-04-28
US20190328799A1 (en) 2019-10-31
PL3432899T3 (pl) 2021-11-22
HUE055635T2 (hu) 2021-12-28
UA127180C2 (uk) 2023-05-31
CA3018625A1 (fr) 2017-09-28
DK3432899T3 (da) 2021-07-05
EP3222282A1 (fr) 2017-09-27
IL261932B2 (en) 2023-04-01

Similar Documents

Publication Publication Date Title
EP3432899B1 (fr) Utilisation de probiotiques dans le traitement et/ou la prévention du psoriasis
US20230048705A1 (en) Use of probiotics in the treatment and/or prevention of atopic dermatitis
EP3673744A1 (fr) Expression du bdnf au niveau hippocampique et de la bifidobacterium longum
AU2020261345A1 (en) Microbial compositions and methods for greater tolerability and prolonged shelf life
CA3018625C (fr) Utilisation de probiotiques dans le traitement et/ou la prevention du psoriasis
HK40000790B (en) Use of probiotics in the treatment and/or prevention of psoriasis
HK40000790A (en) Use of probiotics in the treatment and/or prevention of psoriasis
OA18880A (en) Use of probiotics in the treatment and/or prevention of psoriasis
EA040422B1 (ru) Применение пробиотиков в лечении и/или профилактике атопического дерматита
BR112018069284B1 (pt) Composição probiótica para uso no tratamento e/ou prevenção de surtos de psoríase e/ou psoríase
HK40009064B (en) Use of probiotics in the treatment and/or prevention of atopic dermatitis
HK40009064A (en) Use of probiotics in the treatment and/or prevention of atopic dermatitis
BR112019001116B1 (pt) Composição probiótica usada no tratamento e/ou prevenção da dermatite atópica
OA19179A (en) Use of probiotics in the treatment and/or prevention of atopic dermatitis.